Voice your opinion on congressional bill HR275-116 and let lawmakers know your stance with UnPac!

Main Subject: Health

Medicare Prescription Drug Price Negotiation Act of 2019

This bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits the CMS from doing so.

House committee actions Actions

Committee
Sep. 25 2019	Subcommittee Hearings Held.
Jan. 25 2019	Referred to the Subcommittee on Health.
Jan. 08 2019	Referred to the Subcommittee on Health.

House floor actions Actions

IntroReferral

Jan. 08
2019

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Library of Congress Actions

IntroReferral
Jan. 08 2019	Introduced in House Introduced in House

House bill HR275-116

Medicare Prescription Drug Price Negotiation Act of 2019

House bill HR275-116

Medicare Prescription Drug Price Negotiation Act of 2019

Promote the cause!

Or use this QR code